Purpose: The purpose of this study was to compare the antigenic potency and stability of tetanus and diphtheria (Td) vaccines when combined with aluminum phosphate (AlPO) and liposome adjuvants.

Materials And Methods: and analyses were conducted using the single radial immunodiffusion method and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The Td vaccines were prepared with AlPO adsorption and liposome-mediated delivery, and protein antigens were characterized using these methods.

Results: The results revealed that the liposome-mediated Td vaccines exhibited higher immunogenicity compared to the AlPO-adsorbed Td vaccines. Additionally, the liposome-mediated Td vaccines demonstrated higher stability as native antigens.

Conclusion: This study highlights the importance of utilizing liposome adjuvants in vaccine development. The liposome-mediated Td vaccines showed enhanced immunogenicity and stability, making them a promising approach for improving vaccine efficacy. Understanding and optimizing adjuvant strategies can contribute to the development of effective vaccines against various diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435775PMC
http://dx.doi.org/10.7774/cevr.2023.12.3.232DOI Listing

Publication Analysis

Top Keywords

liposome-mediated vaccines
12
vaccines
7
liposome-mediated
5
immunogenic characterization
4
characterization alpo
4
alpo adsorbed
4
vaccine
4
adsorbed vaccine
4
vaccine liposome-mediated
4
liposome-mediated vaccine
4

Similar Publications

Purpose: The purpose of this study was to compare the antigenic potency and stability of tetanus and diphtheria (Td) vaccines when combined with aluminum phosphate (AlPO) and liposome adjuvants.

Materials And Methods: and analyses were conducted using the single radial immunodiffusion method and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The Td vaccines were prepared with AlPO adsorption and liposome-mediated delivery, and protein antigens were characterized using these methods.

View Article and Find Full Text PDF

The advancements in the field of nanotechnology have provided a great platform for the development of effective antiviral vaccines. Liposome-mediated delivery of antigens has been shown to induce the antigen-specific stimulation of the humoral and cell-mediated immune responses. Here, we prepared dried, reconstituted vesicles (DRVs) from DPPC liposomes and used them as the vaccine carrier system for the Middle East respiratory syndrome coronavirus papain-like protease (DRVs-MERS-CoV PLpro).

View Article and Find Full Text PDF

Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of (MSP-Fu) Mounts Protective Immune Response.

Nanomaterials (Basel)

February 2021

Division of Cell Biology and Immunology, Biomedical Parasitology and Nano-Immunology Lab., CSIR-Institute of Microbial Technology (IMTECH), Sec-39A, Chandigarh 160036, India.

Transdermal immunization exhibits poor immunogenic responses due to poor permeability of antigens through the skin. Elastic liposomes, the ultradeformable nanoscale lipid vesicles, overcome the permeability issues and prove a versatile nanocarrier for transcutaneous delivery of protein, peptide, and nucleic acid antigens. Elastic liposome-mediated subcutaneous delivery of chimeric fusion protein (MSP-Fu) of exhibited improved immunogenic responses.

View Article and Find Full Text PDF

HER2/neu is an immunogenic protein inducing both humoral and cell-mediated immune responses. The antigen-specific cytotoxic T lymphocytes (CTLs) are the main effector immune cells in the anti-tumor immunity. To induce an effective CTL specific response against P5+435 single peptide derived from rat HER2/neu oncogene, we used a liposome delivery vehicle.

View Article and Find Full Text PDF

Successful therapeutic vaccination would allow locally delivered oncolytic virus (OV) to exert systemic immunologic effects on metastases and improve survival. We have utilized bilateral flank tumor models to determine the most efficacious regimens of vaccination. Intratumoral injection with membrane-tethered interleukin -2-armed OV (vvDD-mIL2) plus a Toll-like receptor 9 ligand (CpG) yielded systemic immunization and decreased tumor growth in a contralateral, noninjected tumor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!